Sanara MedTech
Sanara MedTech

Sanara MedTech

Health Care Equipment & Supplies
WebsiteInvestor RelationsSEC
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

$290.9M

Market Cap • 11/10/2026

2001

(25 years)

Founded

2020

(6 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

36,6

P/S

2,6

P/EBITDA

25,7

P/OCF

51,1

P/FCF

64,6

P/E

—

BVPS

0,9

EPS

—

Market Cap

Market Cap

290,9M

EV

324M

EV/Revenue

3

EV/EBITDA

28,6

EV/EBIT

38,5

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0,1%

Total Yield

0,1%

Payout

0%

Retained Earnings

-74,9M

Profitability

Gross Margin

93%

EBITDA Margin

10,3%

EBIT Margin

7,7%

Net Margin

—

D&A/EBITDA

21,9%

R&D/Revenue

4,5%

Capex/Revenue

1,1%

Capex/D&A

40,9%

Capex/OCF

20,9%

SBC/OCF

86,7%

% PPE

3,4%

% Goodwill

5,2%

ROE

—

ROIC

15,5%

Growth

CAGR Revenue 5Y

40%

CAGR Net Income 5Y

-41,8%

CAGR EPS 5Y

-28,9%

Leverage

N.D./EBITDA

2,9

Debt/Equity

0%

Current Ratio

2,6

Quick Ratio

2,2

Interest Coverage

115,9%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium